Innovita Biological Technology Co. Ltd. A (688253) — Financial Flexibility Index
Innovita Biological Technology Co. Ltd. A (688253) has a Financial Flexibility Index of 1.00x as of December 2025. Free cash flow of CN¥224.26 Million (operating CF CN¥193.13 Million minus capex CN¥31.13 Million) represents 1% of total liabilities (CN¥223.32 Million). Check how resilient are Innovita Biological Technology Co. Ltd. 's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Innovita Biological Technology Co. Ltd. A Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Innovita Biological Technology Co. Ltd. A across 6 annual periods. See 688253 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year free cash flow to debt coverage for Innovita Biological Technology Co. Ltd. A. For the full company profile including market capitalisation, see Innovita Biological Technology Co. Ltd. (688253) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | CN¥224.26 Million | CN¥193.13 Million | CN¥223.32 Million | ▼ -35.6% |
| 2024 | 1.56x | CN¥341.62 Million | CN¥305.46 Million | CN¥219.07 Million | ▲ +26.0% |
| 2023 | 1.24x | CN¥276.82 Million | CN¥259.85 Million | CN¥223.65 Million | ▲ +70.2% |
| 2022 | 0.73x | CN¥184.14 Million | CN¥126.43 Million | CN¥253.24 Million | ▼ -74.5% |
| 2021 | 2.85x | CN¥170.02 Million | CN¥106.27 Million | CN¥59.70 Million | ▼ -54.7% |
| 2020 | 6.28x | CN¥716.53 Million | CN¥639.82 Million | CN¥114.08 Million | — |